drugset / Trial / NCT01121653

Impact of Oral Magnesium on Neuropathic Pain

NCT01121653

Phase 4 Completed 50 enrolled University Hospital, Clermont-Ferrand
RandomizedDouble-blindTreatment

Summary

Use lay language. The aim of this study is to evaluate on pain scores (neuropathic pain questionnaire and pain numeric scale) and on quality of life, the effect of oral magnesium intake on patients with neuropathic pain comparing with patients receiving placebo,. The study drug will be taken during 4 weeks.

Timeline

Start
2006-03
Primary completion
2008-01
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified Oral

Indications